首页 › 期刊 › Integrative Medicine in Nephrology and Andrology
Integrative Medicine in Nephrology and Andrology
出版商:Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins · ISSN:2773-0387, 2773-0395 · 类型:journal
研究主题:Chronic Kidney Disease and Diabetes · Renal Diseases and Glomerulopathies · COVID-19 Clinical Research Studies · Dialysis and Renal Disease Management · Acute Kidney Injury Research
数据覆盖:4 个公开学术数据源交叉核验(crossref、jcr、openalex、xr)。
数据来源与实体核验
核心指标
- 影响因子(JCR 2025):7.400
- JCR 分区:Q1(INTEGRATIVE & COMPLEMENTARY MEDICINE)
- 新锐分区(2026):医学 2区
- h-index:15
- i10 指数:28
- 近两年篇均被引:6.51
- 载文量 143 · 总被引 879
- Crossref DOI 总量:143,近期 84
同学科期刊推荐
- The American Journal of Chinese Medicine — IF 7.8 · JCR Q1 · 中科院2区
- Chinese Journal of Natural Medicines — IF 7.5 · JCR Q1 · 中科院2区
- Acupuncture and Herbal Medicine — IF 7.3 · JCR Q1 · 中科院4区
- Journal of Integrative Medicine — IF 5.2 · JCR Q1 · 中科院2区
- Integrative Medicine Research — IF 4.9 · JCR Q1 · 中科院3区
- BMC Complementary Medicine and Therapies — IF 4.4 · JCR Q1 · 中科院3区
- Complementary Therapies in Medicine — IF 4.0 · JCR Q1 · 中科院3区
- Journal of Traditional and Complementary Medicine — IF 3.9 · JCR Q2 · 中科院3区
常见问题
《Integrative Medicine in Nephrology and Andrology》的影响因子是多少?
根据 JCR 2025 年数据,《Integrative Medicine in Nephrology and Andrology》的最新影响因子(IF)为 7.400。
《Integrative Medicine in Nephrology and Andrology》是几区期刊?
《Integrative Medicine in Nephrology and Andrology》JCR 分区为 Q1。
本刊近期代表论文
- Gut Microbiota and Membranous Nephropathy: Novel Molecular Mechanisms and Natural Product Therapeutic Strategies (2025 · 被引 13)
- The Clinical Effectiveness of Anti-TGF-β Therapy in Chronic Kidney Disease: A Systematic Review of Western and Traditional Chinese Medicine (2025 · 被引 5)
- Integrating Traditional Chinese Medicine in the Management of Podocytopathies (2025 · 被引 4)
- Traditional Chinese Medicine as a Promising Therapy for Patients with Membranous Nephropathy (2025 · 被引 4)
- Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy (2024 · 被引 54)
- Gut Microbiota-derived Metabolites: A New Perspective of Traditional Chinese Medicine Against Diabetic Kidney Disease (2024 · 被引 45)